Annual EBITDA
$2.17B$265.00M+13.89%
Summary
- Current Value
- As of today, DGX annual EBITDA is $2.17B, up +13.89% on
- Historical Performance
- DGX annual EBITDA is up +5.54% over the past 3 years, down -11.88% over the past 5 years
- All-Time High Comparison
- DGX annual EBITDA is currently -23.81% below its historical high of $2.85B set on
- 3-Year Low Comparison
- DGX annual EBITDA is +21.40% above its 3-year low of $1.79B reached on
- Sector Comparison
- DGX annual EBITDA is higher than 96.15% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $2.17B | +13.9% | +5.5% | -11.9% | +37.0% | |
| Quarterly EBITDA | $536.00M | +5.3% | +31.7% | -42.4% | +42.9% | |
| TTM EBITDA | $2.17B | +14.0% | +5.5% | -11.7% | +37.0% | |
| Price | $202.41 | +17.6% | +36.6% | +69.8% | +251.7% | |
| PE Ratio | 23.12 | +3.4% | +23.4% | +102.1% | +62.7% | |
| Annual Revenue | $11.04B | +11.8% | +11.7% | +16.9% | +49.8% | |
| Annual EPS | $8.75 | +14.2% | +9.6% | -16.8% | +116.0% | |
| $1.60B | +13.3% | -1.2% | -23.9% | +20.4% | ||
| Annual Net Income | $1.04B | +13.8% | +3.1% | -30.2% | +37.9% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $2.17B | at high | |
| 5Y | $2.85B | -23.8% | |
| All | $2.85B | -23.8% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $1.79B | +21.4% | |
| 5Y | $1.79B | +21.4% | |
| All | $157.95M | +1275.7% |
EBITDA History
FAQ
What is the current annual EBITDA of DGX?
As of today, DGX annual EBITDA is $2.17B
What is 1-year change in DGX annual EBITDA?
DGX annual EBITDA is up +13.89% year-over-year
What is 3-year change in DGX annual EBITDA?
DGX annual EBITDA is up +5.54% over the past 3 years
How far is DGX annual EBITDA from its all-time high?
DGX annual EBITDA is currently -23.81% below its historical high of $2.85B set on December 31, 2021
How does DGX annual EBITDA rank versus sector peers?
DGX annual EBITDA is higher than 96.15% of companies in Healthcare sector
When is DGX next annual earnings release?
As of today, the next annual earnings release for DGX has not been scheduled
Quarterly EBITDA
$536.00M$26.00M-4.63%
Summary
- Current Value
- As of today, DGX quarterly EBITDA is $536.00M, down -4.63% on
- Historical Performance
- DGX quarterly EBITDA is up +5.30% year-over-year, up +31.70% over the past 3 years
- All-Time High Comparison
- DGX quarterly EBITDA is currently -42.37% below its historical high of $930.00M set on
- 3-Year Low Comparison
- DGX quarterly EBITDA is +31.70% above its 3-year low of $407.00M reached on an earlier date
- Sector Comparison
- DGX quarterly EBITDA is higher than 95.79% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $536.00M | -4.6% | +5.3% | +31.7% | -42.4% | |
| Annual EBITDA | $2.17B | – | +13.9% | +5.5% | -11.9% | |
| TTM EBITDA | $2.17B | +1.3% | +14.0% | +5.5% | -11.7% | |
| Price | $202.41 | +7.9% | +17.6% | +36.6% | +69.8% | |
| PE Ratio | 23.12 | +5.0% | +3.4% | +23.4% | +102.1% | |
| Quarterly Revenue | $2.81B | -0.4% | +7.1% | +20.3% | -6.5% | |
| Quarterly EPS | $2.18 | +1.4% | +12.0% | +148.2% | -48.1% | |
| $391.00M | -6.9% | +4.5% | +34.4% | -53.0% | ||
| Quarterly Net Income | $256.00M | -0.4% | +9.4% | +120.7% | -57.8% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $568.00M | -5.6% | |
| 3Y | $568.00M | -5.6% | |
| 5Y | $930.00M | N/A | -42.4% |
| All | $930.00M | -42.4% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $507.00M | +5.7% | |
| 3Y | $407.00M | N/A | +31.7% |
| 5Y | $407.00M | +31.7% | |
| All | $27.70M | +1835.0% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of DGX?
As of today, DGX quarterly EBITDA is $536.00M
What is DGX quarterly EBITDA most recent change?
DGX quarterly EBITDA was down -4.63% on December 31, 2025
What is 1-year change in DGX quarterly EBITDA?
DGX quarterly EBITDA is up +5.30% year-over-year
How far is DGX quarterly EBITDA from its all-time high?
DGX quarterly EBITDA is currently -42.37% below its historical high of $930.00M set on December 31, 2020
How does DGX quarterly EBITDA rank versus sector peers?
DGX quarterly EBITDA is higher than 95.79% of companies in Healthcare sector
When is DGX next earnings release?
The next earnings release for DGX is on
TTM EBITDA
$2.17B$27.00M+1.26%
Summary
- Current Value
- As of today, DGX TTM EBITDA is $2.17B, up +1.26% on
- Historical Performance
- DGX TTM EBITDA is up +14.01% year-over-year, up +5.54% over the past 3 years
- All-Time High Comparison
- DGX TTM EBITDA is currently -33.28% below its historical high of $3.26B set on
- 3-Year Low Comparison
- DGX TTM EBITDA is +21.26% above its 3-year low of $1.79B reached on
- Sector Comparison
- DGX TTM EBITDA is higher than 96.06% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $2.17B | +1.3% | +14.0% | +5.5% | -11.7% | |
| Annual EBITDA | $2.17B | – | +13.9% | +5.5% | -11.9% | |
| Quarterly EBITDA | $536.00M | -4.6% | +5.3% | +31.7% | -42.4% | |
| Price | $202.41 | +7.9% | +17.6% | +36.6% | +69.8% | |
| PE Ratio | 23.12 | +5.0% | +3.4% | +23.4% | +102.1% | |
| TTM Revenue | $11.04B | +1.7% | +11.8% | +11.7% | +16.9% | |
| TTM EPS | $8.76 | +2.7% | +13.8% | +10.6% | -16.0% | |
| $1.60B | +1.1% | +13.4% | -1.2% | -23.7% | ||
| TTM Net Income | $1.04B | +2.2% | +13.8% | +3.1% | -30.2% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $2.17B | at high | |
| 3Y | $2.17B | at high | |
| 5Y | $3.26B | -33.3% | |
| All | $3.26B | -33.3% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $1.91B | N/A | +14.0% |
| 3Y | $1.79B | +21.3% | |
| 5Y | $1.79B | +21.3% | |
| All | $38.40M | +5558.9% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of DGX?
As of today, DGX TTM EBITDA is $2.17B
What is DGX TTM EBITDA most recent change?
DGX TTM EBITDA was up +1.26% on December 31, 2025
What is 1-year change in DGX TTM EBITDA?
DGX TTM EBITDA is up +14.01% year-over-year
How far is DGX TTM EBITDA from its all-time high?
DGX TTM EBITDA is currently -33.28% below its historical high of $3.26B set on June 30, 2021
How does DGX TTM EBITDA rank versus sector peers?
DGX TTM EBITDA is higher than 96.06% of companies in Healthcare sector
When is DGX next earnings release?
The next earnings release for DGX is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- DGX Official Website www.questdiagnostics.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1022079/000102207926000005/0001022079-26-000005-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1022079/000102207926000005/0001022079-26-000005-index.htm
- DGX Profile on Yahoo Finance finance.yahoo.com/quote/DGX
- DGX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/dgx